Fabrizio Benedicenti

5.1k total citations · 1 hit paper
27 papers, 1.9k citations indexed

About

Fabrizio Benedicenti is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Fabrizio Benedicenti has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Genetics and 11 papers in Oncology. Recurrent topics in Fabrizio Benedicenti's work include Virus-based gene therapy research (23 papers), CRISPR and Genetic Engineering (12 papers) and CAR-T cell therapy research (11 papers). Fabrizio Benedicenti is often cited by papers focused on Virus-based gene therapy research (23 papers), CRISPR and Genetic Engineering (12 papers) and CAR-T cell therapy research (11 papers). Fabrizio Benedicenti collaborates with scholars based in Italy, United States and Germany. Fabrizio Benedicenti's co-authors include Eugenio Montini, Luigi Naldini, Daniela Cesana, Manfred Schmidt, Christof von Kalle, Francesca Sanvito, Lucia Sergi Sergi, Claudio Doglioni, Cynthia C. Bartholomae and Clelia Di Serio and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Fabrizio Benedicenti

27 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

2006 537 citations Eugenio Montini, Daniela Cesana et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Fabrizio Benedicenti

Since Specialization

Citations

This map shows the geographic impact of Fabrizio Benedicenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Benedicenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Benedicenti more than expected).

Fields of papers citing papers by Fabrizio Benedicenti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizio Benedicenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Benedicenti. The network helps show where Fabrizio Benedicenti may publish in the future.

Co-authorship network of co-authors of Fabrizio Benedicenti

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio Benedicenti. A scholar is included among the top collaborators of Fabrizio Benedicenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio Benedicenti. Fabrizio Benedicenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy 2023 ·Nature Communications ·Serena Scala, (unknown), Luca Basso‐Ricci, Francesca Dionisio, (unknown), (unknown), Raisa Jofra Hernández, (unknown), Fabrizio Benedicenti, (unknown), Stefania Giannelli, (unknown), (unknown), Elena Albertazzi, Stefania Galimberti, Eugenio Montini, Andrea Calabria, Maria Pia Cicalese, Alessandro Aiuti	9
2	Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci 2023 ·Blood ·Andrea Calabria, (unknown), Giulio Spinozzi, (unknown), Simona Esposito, Fabrizio Benedicenti, (unknown), Marie Pouzolles, Mirko Luoni, Serena Giannelli, Vania Broccoli, Mickaël Guilbaud, Oumeya Adjali, Naomi Taylor, Valérie S. Zimmermann, Eugenio Montini, Daniela Cesana	4
3	InCliniGene enables high-throughput and comprehensive in vivo clonal tracking toward clinical genomics data integration 2023 ·Database ·Ivan Merelli, Stefano Beretta, Daniela Cesana, (unknown), Fabrizio Benedicenti, Giulio Spinozzi, Daniele Cesini, Eugenio Montini, Daniele D’Agostino, Andrea Calabria	1
4	Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells 2023 ·Molecular Therapy ·(unknown), Giulia Unali, (unknown), (unknown), (unknown), Fabrizio Benedicenti, Maria Rosa Lidonnici, Ivan Cuccovillo, (unknown), (unknown), Giulio Spinozzi, Ivan Merelli, Rayk Behrendt, Adrian Oo, Baek Kim, Nathaniel R. Landau, Giuliana Ferrari, Eugenio Montini, Anna Kajaste‐Rudnitski	6
5	ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications 2022 ·Briefings in Bioinformatics ·(unknown), Giulio Spinozzi, Daniela Cesana, Fabrizio Benedicenti, (unknown), Maria Ester Bernardo, Bernhard Gentner, Eugenio Montini, Andrea Calabria	4
6	Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device 2021 ·Molecular Therapy — Methods & Clinical Development ·Cristina Olgasi, Chiara Borsotti, Simone Merlin, Thorsten Bergmann, (unknown), (unknown), Nicholas M. Wragg, (unknown), Andrea Calabria, Fabrizio Benedicenti, Alessia Cucci, Alessandra Borchiellini, (unknown), Eugenio Montini, Delfina M. Mazzuca, (unknown), Alexandra Stolzing, Philip M. Toleikis, Joris Braspenning, Antonia Follenzi	12
7	Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant Ex Vivo Gene Therapy Settings 2019 ·Human Gene Therapy ·Carolina Petrillo, Andrea Calabria, (unknown), Alessia Capotondo, Giulio Spinozzi, Ivan Cuccovillo, Fabrizio Benedicenti, Luigi Naldini, Eugenio Montini, Alessandra Biffi, Bernhard Gentner, Anna Kajaste‐Rudnitski	8
8	Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells 2019 ·Journal of Allergy and Clinical Immunology ·Marie Pouzolles, (unknown), Mickaël Guilbaud, Magali Irla, (unknown), (unknown), Daniela Cesana, Andrea Calabria, Fabrizio Benedicenti, Arnauld Sergé, Indu Raman, Quan‐Zhen Li, Eugenio Montini, David Klatzmann, Oumeya Adjali, Naomi Taylor, Valérie S. Zimmermann	8
9	Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency 2016 ·Molecular Therapy ·(unknown), Andrea Calabria, María García‐Bravo, Fabrizio Benedicenti, Penelope A. Kosinski, (unknown), Collin Hill, María del Mar Mañú‐Pereira, Miguel A. Martı́n, Israel Orman, Joan‐Lluís Vives Corrons, Charles Kung, Axel Schambach, Shengfang Jin, Juan A. Bueren, Eugenio Montini, Susana Navarro, José C. Segovia	43
10	miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia 2016 ·Cancer Cell ·Silvia Nucera, Alice Giustacchini, Francesco Boccalatte, Andrea Calabria, Cristiana Fanciullo, Tiziana Plati, Anna Ranghetti, José Manuel García-Manteiga, Davide Cittaro, Fabrizio Benedicenti, Eric R. Lechman, John E. Dick, Maurilio Ponzoni, Fabio Ciceri, Eugenio Montini, Bernhard Gentner, Luigi Naldini	52
11	Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform 2016 ·Oncotarget ·Chiara F. Magnani, (unknown), Fabrizio Benedicenti, Andrea Calabria, Erika Tenderini, Sarah Tettamanti, Greta Maria Paola Giordano Attianese, Laurence J.N. Cooper, Alessandro Aiuti, Eugenio Montini, Andrea Biondi, Ettore Biagi	42
12	Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting 2015 ·Gene Therapy ·Martina Cesani, Tiziana Plati, Laura Lorioli, Fabrizio Benedicenti, Daniela Redaelli, Francesca Dionisio, Luca Biasco, Eugenio Montini, Luigi Naldini, Alessandra Biffi	11
13	VISPA: a computational pipeline for the identification and analysis of genomic vector integration sites 2014 ·Genome Medicine ·Andrea Calabria, Simone Leo, Fabrizio Benedicenti, Daniela Cesana, Giulio Spinozzi, (unknown), Stefania Merella, Elia Stupka, Gianluigi Zanetti, Eugenio Montini	22
14	Uncovering and Dissecting the Genotoxicity of Self-inactivating Lentiviral Vectors In Vivo 2014 ·Molecular Therapy ·Daniela Cesana, Marco Ranzani, Monica Volpin, Cynthia C. Bartholomae, (unknown), (unknown), Stefania Merella, Fabrizio Benedicenti, Lucia Sergi Sergi, Francesca Sanvito, Chiara Brombin, Alessandro Nonis, Clelia Di Serio, Claudio Doglioni, Christof von Kalle, Manfred Schmidt, Odile Cohen‐Haguenauer, Luigi Naldini, Eugenio Montini	148
15	Lentiviral Vector-based Insertional Mutagenesis Identifies Genes Involved in the Resistance to Targeted Anticancer Therapies 2014 ·Molecular Therapy ·Marco Ranzani, Stefano Annunziato, Andrea Calabria, (unknown), Fabrizio Benedicenti, Pierangela Gallina, Luigi Naldini, Eugenio Montini	14
16	Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy 2014 ·Human Molecular Genetics ·Annalisa Lattanzi, Camilla Salvagno, Claudio Maderna, Fabrizio Benedicenti, Francesco Morena, Willem Kulik, Luigi Naldini, Eugenio Montini, Sabata Martino, Angela Gritti	44
17	Lentiviral vector–based insertional mutagenesis identifies genes associated with liver cancer 2013 ·Nature Methods ·Marco Ranzani, Daniela Cesana, Cynthia C. Bartholomae, Francesca Sanvito, Mauro Pala, Fabrizio Benedicenti, Pierangela Gallina, Lucia Sergi Sergi, Stefania Merella, Alessandro Bulfone, Claudio Doglioni, Christof von Kalle, Yoon Jun Kim, Manfred Schmidt, Giovanni Tonon, Luigi Naldini, Eugenio Montini	78
18	The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy 2009 ·Journal of Clinical Investigation ·Eugenio Montini, Daniela Cesana, Manfred Schmidt, Francesca Sanvito, Cynthia C. Bartholomae, Marco Ranzani, Fabrizio Benedicenti, Lucia Sergi Sergi, Alessandro Ambrosi, Maurilio Ponzoni, Claudio Doglioni, Clelia Di Serio, Christof von Kalle, Luigi Naldini	413
19	Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration breakdown → 2006 ·Nature Biotechnology ·Eugenio Montini, Daniela Cesana, Manfred Schmidt, Francesca Sanvito, Maurilio Ponzoni, Cynthia C. Bartholomae, Lucia Sergi Sergi, Fabrizio Benedicenti, Alessandro Ambrosi, Clelia Di Serio, Claudio Doglioni, Christof von Kalle, Luigi Naldini	537
20	Efficient Tet-Dependent Expression of Human Factor IX in Vivo by a New Self-Regulating Lentiviral Vector 2005 ·Molecular Therapy ·Elisa Vigna, Mario Amendola, Fabrizio Benedicenti, Andrew D. Simmons, Antonia Follenzi, Luigi Naldini	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact